Mesothelioma News

This year’s American Society of Clinical Oncology’s meeting had to be held virtually in light of the global pandemic, but that has in no way interfered with the revelations of remarkable progress in the treatment of malignant pleural mesothelioma.  Among the presentations was news that Italian researchers have significantly improved survival among mesothelioma patients by treating

Read More

Mesothelioma advocates are criticizing EPA decisions as the agency announces another delay in its evaluation of asbestos and its potential for harm. Blaming the challenges created by the global pandemic, EPA chief Andrew Wheeler informed the Senate Environment and Public Works Committee that it would not be able to meet the statutory deadline of June

Read More

A study analyzing characteristics of patients with thoracic cancers like malignant mesothelioma who developed COVID-19 revealed that patients who had received chemotherapy within three months of their diagnosis with the virus had a significantly increased risk of death. The information was presented ahead of the 2020 American Society of Clinical Oncology Virtual Scientific Program, and

Read More

In the hierarchy of treatments used for malignant mesothelioma, radiation therapy has frequently been ranked the lowest: though it can help to provide symptom relief, it has not generally been credited for extended survival or progression free survival. Now a study out of Turkey has introduced statistics that show the use of innovative targeted therapies

Read More

Though people diagnosed with malignant pleural mesothelioma are told at the outset that their condition is both incurable and fatal, that does nothing to stop them from pinning their hopes on innovative medical treatments. Some of those hopes may be fulfilled, as a recent test of a genetically modified virus has proven capable of infecting

Read More

The results are in from a phase II study that tested a combination of standard chemotherapy with a new immunotherapy drug on patients diagnosed with malignant mesothelioma, and the results have been described as “remarkable.” The immunotherapy drug is durvalumab (brand name Infinzi) and it was developed by Medimmune/AstraZeneca. The results will be presented at

Read More

If you have a known exposure to asbestos, whether from the workplace, exposure to a family member who worked with the substance, or some other source, you have long been aware of your risk for malignant mesothelioma, asbestosis, and other asbestos-related diseases. As if those fears were not stressful enough, those same individuals are now

Read More

While multi-million-dollar mesothelioma lawsuits against Johnson & Johnson’s Baby Powder have been capturing headlines, litigation against the company’s talc provider Imerys led the smaller organization to file for bankruptcy last year. This week they announced that they will be selling their North American operations and using the assets to settle more than 14,000 lawsuits against

Read More

In the face of thousands of lawsuits accusing their product of causing malignant mesothelioma and ovarian cancer, Johnson & Johnson has announced that they will no longer sell their talc-based baby powder product in the United States or Canada. The product has long been one of the world’s most recognizable and trusted consumer products.

Read More

Malignant mesothelioma is an asbestos-related disease that is traditionally (and appropriately) associated with occupational settings. Most victims are those who have been exposed to the carcinogen in factories, in high-heat settings like boiler rooms, and while working on construction sites doing insulation work, working with asbestos concrete, and ceiling and floor tile installation or removal.

Read More

For researchers investigating malignant mesothelioma, any progress — no matter how incremental — is to be celebrated. The disease has proven remarkably resistant to treatment, so when scientists identify a way to slow the rare form of cancer’s spread it is notable. Such is the case of a recent discovery by Italian researchers that is detailed

Read More

Malignant mesothelioma is one of the most challenging types of cancer to treat. This is partially due to the disease not being diagnosed until it is in an advanced stage, and partially due to its extreme resistance to chemotherapy. That resistance has been linked to a variety of genetic mutations including a mutation in the

Read More

COVID-19 has struck fear into the hearts of people all over the world, but perhaps none as much as those at high risk due to serious illnesses like malignant mesothelioma. Cancer patients are not only generally more vulnerable to disease: they also rely upon regular medical treatment, and going for those treatments in the presence

Read More

The United States sees an average of 3,500 people diagnosed with malignant mesothelioma each and every year, and a large proportion of those who have the disease are able to track their asbestos exposure to their days working on ships or in actually building seagoing vessels. That trend is not unique to the United States,

Read More

All around the country people’s lives have been turned upside down by COVID-19, but perhaps none so much as those who were already dealing with the unthinkable — a mesothelioma diagnosis.  Where the rest of us are rightly concerned about jobs lost or put on hold, separation from family members and friends, and the availability of

Read More

For those diagnosed with malignant mesothelioma, an additional few months of feeling good and being able to maintain a normal quality of life is a great gift, and that is what researchers from Madrid’s 12 de Octubre University Hospital are seeing from their testing of a new first-line treatment called ONCOS-102. According to principal investigator Luis

Read More

Malignant mesothelioma diagnoses rarely command headlines in local newspapers, and especially not in the paper for the sixth-most populous city in the country. But that is exactly what is happening in the city of Philadelphia, where the Philadelphia Inquirer is closely following the case of Lea DiRusso.

Read More

In the battle against malignant mesothelioma, one of the biggest frustrations endured by both physicians and patients is the fact that the disease has proven so resistant to traditional treatments. Even the only chemotherapy treatment to receive FDA approval for treatment of the asbestos-related disease provides only marginal results, delivering harmful side effects with only

Read More

Mention an asbestos-related disease and malignant mesothelioma is likely the first that comes to mind. But according to a recent study conducted by researchers from Finland and Australia, the carcinogenic material is likely to blame for many other types of cancer, and particularly for lung cancer in those who smoke.

Read More

Mesothelioma lawsuits are all about getting justice. A person who has been diagnosed with the rare and fatal form of cancer – or sometimes their surviving loved ones – is seeking compensation for the loss that they have suffered as a result of a company exposing them to the carcinogenic material that caused their illness

Read More